• 9 October 2018

    September’s top news stories

    Emerald Health Pharmaceuticals (EHP) started patient enrolment for its Phase I clinical trial of EHP-101 for the treatment of patients with multiple sclerosis (MS) and scleroderma, and Ra Pharmaceuticals reported...

  • 4 May 2018

    April’s top news stories

    The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended three medications for approval during its April meeting, and Drug development company Proniras has entered...

  • 30 April 2018

    EMA recommends three medicines for approval

    The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended three medications for approval during its April meeting.

Go Top